Lennox-Gastaut Syndrome Market is Likely to Increase at a Steady Growth Rate by 2032, Estimates DelveInsight | Key Players to Watch Out - Zogenix, Epygenix, SK Life Science, Takeda, Jazz Pharmaceuticals, Longboard Pharmaceuticals
October 05, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Lennox-Gastaut Syndrome Market is Likely to Increase at a Steady Growth Rate by 2032, Estimates DelveInsight | Key Players to Watch Out - Zogenix,...
Health Canada Issues No Objection Letter to Initiate the ELEGANSE Trial With EPX-100 to Treat Lennox-Gastaut Syndrome
February 16, 2022 05:00 ET
|
Epygenix Therapeutics, Inc.
PARAMUS, N.J., Feb. 16, 2022 (GLOBE NEWSWIRE) -- Epygenix Therapeutics, Inc. ("Epygenix"), a clinical stage biopharmaceutical company focused on rare and intractable genetic epilepsy, announced...